Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nowell Solish

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Journal of Cutaneous Medicine and Surgery|July 24, 2018
Patient Indications for Mohs Micrographic Surgery: A Systematic ReviewChristian Murray, Duvaraga Sivajohanathan, Timothy P Hanna, et al.
Plastic and Reconstructive Surgery. Global Open|June 16, 2020
OnabotulinumtoxinA Treatment for Moderate to Severe Forehead Lines: A ReviewKoenraad De Boulle, Alastair Carruthers, Nowell Solish, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 29, 2015
Subject satisfaction with onabotulinumtoxinA treatment of glabellar and lateral canthal lines using a new patient-reported outcome measureJason K Rivers, Vince Bertucci, William McGillivray, et al.
Journal of the American Academy of Dermatology|December 4, 2019
DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)Vince Bertucci, Nowell Solish, Joely Kaufman-Janette, et al.
Aesthetic Surgery Journal. Open Forum|February 20, 2025
Canada HARMONY Study: Improvements in Patient Satisfaction With Facial Appearance and Psychological Impact of Combined Aesthetic TreatmentJason K Rivers, Vince Bertucci, Channy Muhn, et al.
Plastic and Reconstructive Surgery|October 7, 2015
Upper Face: Clinical Anatomy and Regional Approaches with Injectable FillersJonathan M Sykes, Sebastian Cotofana, Patrick Trevidic, et al.
Journal of Drugs in Dermatology : JDD|April 2, 2024
Effectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin RetrusionAndreas Nikolis, Shannon Humphrey, Jason K Rivers, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 15, 2017
Injectable DaxibotulinumtoxinA for the Treatment of Glabellar Lines: A Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Comparison With OnabotulinumtoxinA and PlaceboJean Carruthers, Nowell Solish, Shannon Humphrey, et al.
Aesthetic Surgery Journal|June 24, 2024
Efficacy and Safety of RelabotulinumtoxinA, a New Ready-to-Use Liquid Formulation Botulinum Toxin: Results From the READY-1 Double-Blind, Randomized, Placebo-Controlled Phase 3 Trial in Glabellar LinesSachin M Shridharani, Amir Moradi, Lisa Donofrio, et al.
Aesthetic Surgery Journal|April 17, 2025
Subject-Reported Outcomes for Glabellar Line Improvement and Satisfaction With the Relabotulinumtoxina Ready-to-Use Liquid Formulation: Data From the Phase 3 READY-1 TrialMichael H Gold, Lisa Donofrio, Sachin Shridharani, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Journal of Cutaneous Medicine and Surgery|July 24, 2018
Patient Indications for Mohs Micrographic Surgery: A Systematic ReviewChristian Murray, Duvaraga Sivajohanathan, Timothy P Hanna, et al.
Plastic and Reconstructive Surgery. Global Open|June 16, 2020
OnabotulinumtoxinA Treatment for Moderate to Severe Forehead Lines: A ReviewKoenraad De Boulle, Alastair Carruthers, Nowell Solish, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 29, 2015
Subject satisfaction with onabotulinumtoxinA treatment of glabellar and lateral canthal lines using a new patient-reported outcome measureJason K Rivers, Vince Bertucci, William McGillivray, et al.
Journal of the American Academy of Dermatology|December 4, 2019
DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)Vince Bertucci, Nowell Solish, Joely Kaufman-Janette, et al.
Aesthetic Surgery Journal. Open Forum|February 20, 2025
Canada HARMONY Study: Improvements in Patient Satisfaction With Facial Appearance and Psychological Impact of Combined Aesthetic TreatmentJason K Rivers, Vince Bertucci, Channy Muhn, et al.
Plastic and Reconstructive Surgery|October 7, 2015
Upper Face: Clinical Anatomy and Regional Approaches with Injectable FillersJonathan M Sykes, Sebastian Cotofana, Patrick Trevidic, et al.
Journal of Drugs in Dermatology : JDD|April 2, 2024
Effectiveness and Safety of a New Hyaluronic Acid Injectable for Augmentation and Correction of Chin RetrusionAndreas Nikolis, Shannon Humphrey, Jason K Rivers, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 15, 2017
Injectable DaxibotulinumtoxinA for the Treatment of Glabellar Lines: A Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Comparison With OnabotulinumtoxinA and PlaceboJean Carruthers, Nowell Solish, Shannon Humphrey, et al.
Aesthetic Surgery Journal|June 24, 2024
Efficacy and Safety of RelabotulinumtoxinA, a New Ready-to-Use Liquid Formulation Botulinum Toxin: Results From the READY-1 Double-Blind, Randomized, Placebo-Controlled Phase 3 Trial in Glabellar LinesSachin M Shridharani, Amir Moradi, Lisa Donofrio, et al.
Aesthetic Surgery Journal|April 17, 2025
Subject-Reported Outcomes for Glabellar Line Improvement and Satisfaction With the Relabotulinumtoxina Ready-to-Use Liquid Formulation: Data From the Phase 3 READY-1 TrialMichael H Gold, Lisa Donofrio, Sachin Shridharani, et al.
Pageof 8